Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?
- PMID: 19668548
- PMCID: PMC2709016
Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?
Abstract
Purpose: To evaluate the benefit of titrating the concentration and exposure time of mitomycin C (MMC) as an adjunct to trabeculectomy.
Methods: This report consists of a retrospective study and a review of the literature. In the study, consecutive glaucoma patients were evaluated who underwent trabeculectomy with adjunctive MMC that was titrated for concentration and exposure time, based on patient's risk factors for surgical failure. After minimum follow-up of 6 months, patients were divided into success (intraocular pressure 7-17 mmHg), hypertension (>17 mmHg) and hypotony (<7 mmHg) groups, which were compared with regard to MMC protocol and patient variables. The literature review included reports of trabeculectomy and adjunctive MMC with and without titration.
Results: One hundred and fifty-five eyes of 155 patients were studied. There were no significant differences between the three outcome groups and MMC protocol (p > 0.05). The only significant patient variable was older age in the hypotony group (p = 0.009). The literature is conflicting regarding the value of titrating MMC as an adjunct in trabeculectomy.
Conclusion: The outcome of trabeculectomy with adjunctive MMC appears to represent a complex interaction of patient and surgical variables. While there is some support for a benefit of titrating MMC according to individual patient variables, there is inadequate evidence at the present time to claim superiority for any MMC protocol, with or without titration.
Keywords: glaucoma surgery; intraocular pressure; mitomycin C; trabeculectomy.
Similar articles
-
Deep sclerectomy and trabeculectomy augmented with Mitomycin C: 2-year post-operative outcomes.Graefes Arch Clin Exp Ophthalmol. 2021 Jul;259(7):1965-1974. doi: 10.1007/s00417-021-05144-w. Epub 2021 Mar 8. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33683432 Free PMC article.
-
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.Eye (Lond). 2003 Jan;17(1):53-62. doi: 10.1038/sj.eye.6700180. Eye (Lond). 2003. PMID: 12579171
-
Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.Ophthalmol Glaucoma. 2018 Sep-Oct;1(2):88-98. doi: 10.1016/j.ogla.2018.07.003. Epub 2018 Jul 30. Ophthalmol Glaucoma. 2018. PMID: 32677614 Clinical Trial.
-
Adjunctive mitomycin C in primary trabeculectomy in young adults: a long-term study of case-matched young patients.Graefes Arch Clin Exp Ophthalmol. 1998 Sep;236(9):652-7. doi: 10.1007/s004170050137. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9782425
-
The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure.Ophthalmology. 1998 Apr;105(4):740-5. doi: 10.1016/S0161-6420(98)94032-5. Ophthalmology. 1998. PMID: 9544650 Clinical Trial.
Cited by
-
Adjustable release of mitomycin C for inhibition of scar tissue formation after filtration surgery.Exp Eye Res. 2013 Nov;116:9-16. doi: 10.1016/j.exer.2013.07.005. Epub 2013 Jul 31. Exp Eye Res. 2013. PMID: 23911951 Free PMC article.
-
Evaluating the efficacy of short duration Mitomycin C in safe surgery system trabeculectomy combined with cataract surgery.Clin Ophthalmol. 2019 May 22;13:849-857. doi: 10.2147/OPTH.S192044. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31190728 Free PMC article.
-
Evaluating the long-term efficacy of short-duration 0.1 mg/ml and 0.2 mg/ml MMC in primary trabeculectomy for primary adult glaucoma.Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1153-9. doi: 10.1007/s00417-015-3028-9. Epub 2015 May 5. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25940554 Clinical Trial.
-
One-year results of trabeculectomy with emphasis on the effect of patients' age.Jpn J Ophthalmol. 2025 Jan;69(1):93-100. doi: 10.1007/s10384-024-01131-w. Epub 2024 Oct 14. Jpn J Ophthalmol. 2025. PMID: 39400665 Free PMC article.
-
Results of XEN45 Gel Stent Implantation in the Treatment of Primary Open-Angle Glaucoma Using 5, 10 or 20 μg Mitomycin C: A Pilot Study.J Ophthalmol. 2024 Oct 26;2024:3895054. doi: 10.1155/2024/3895054. eCollection 2024. J Ophthalmol. 2024. PMID: 39492955 Free PMC article.
References
-
- Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia Pac Acad Ophthalmol. 1983;9:172–7.
-
- Chen CW, Huang HT, Bair JS, et al. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol. 1990;6:175–82. - PubMed
-
- Kitazawa Y, Kawase K, Matsushita H, et al. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109:1693–8. - PubMed
-
- Skuta GL, Beeson CC, Higginotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99:438–44. - PubMed
-
- Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-Fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1995;103:1263–9. - PubMed
LinkOut - more resources
Full Text Sources